Journal of Infection
Volume 60, Issue 3 , Pages 191-199 , March 2010

Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors

  • Ulrich Stab Jensen

      Affiliations

    • National Center for Antimicrobials and Infection Control, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark
    • Department of Clinical Microbiology, Copenhagen University Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark
    • Corresponding Author InformationCorresponding author at: National Center for Antimicrobials and Infection Control, Statens Serum Institut, 5, Artillerivej (46/101), DK-2300 Copenhagen S, Denmark. Tel.: +45 3268 8183; fax: +45 3268 3231.
    • ,
  • Jenny Dahl Knudsen

      Affiliations

    • Department of Clinical Microbiology, Copenhagen University Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark
    • ,
  • Christian Østergaard

      Affiliations

    • Department of Clinical Microbiology, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
    • ,
  • Kim Oren Gradel

      Affiliations

    • Department of Clinical Epidemiology, Aarhus University Hospital, Sdr. Skovvej 15, 9000 Aalborg, Denmark
    • Department of Infectious Diseases, Aarhus University Hospital, Mølleparkvej 4, 9100 Aalborg, Denmark
    • ,
  • Niels Frimodt-Møller

      Affiliations

    • National Center for Antimicrobials and Infection Control, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark
    • ,
  • Henrik Carl Schønheyder

      Affiliations

    • Department of Clinical Microbiology, Aarhus University Hospital, Mølleparkvej 8 A, 9100 Aalborg, Denmark

,Accepted 10 December 2009.

References 

  1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554
  2. King MD, Whitney CG, Parekh F, Farley M. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029–1036
  3. Turett GS, Blum S, Telzak EE. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med. 2001;161:2141–2144
  4. Kreisel K, Boyd K, Langenberg P, Roghmann MC. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis. 2006;55:179–184
  5. Fowler VG, Kong LK, Corey GR, Gottlieb GS, McClelland RS, Sexton DJ, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis. 1999;179:1157–1161
  6. Galofre J, Moreno A, Mensa J, Miró JM, Gatell JM, Almela M, et al. Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia. Clin Infect Dis. 1994;18:873–878
  7. Hsu RB, Chen RJ, Chu SH. Risk factors for recurrent bacteremia in adult patients with nontyphoid salmonellosis. Am J Med Sci. 2004;328:315–318
  8. Sanz-Garcia M, Fernandez-Cruz A, Rodriguez-Creixems M, Cercenado E, Marin M, Munoz P, et al. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors. Medicine (Baltimore). 2009;88:77–82
  9. Mylotte JM, McDermott C. Recurrent Gram-negative bacteremia. Am J Med. 1988;85:159–163
  10. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA. Recurrent Gram-negative bacteremia: incidence and clinical patterns. Clin Infect Dis. 1999;28:611–617
  11. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med. 2002;347:2020–2029
  12. Kontoyiannis DP, Reddy BT, Hanna H, Bodey GP, Tarrand J, Raad . Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol. 2002;23:542–545
  13. Einarsdottir HM, Erlendsdottir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect. 2005;11:744–7449
  14. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis. 1983;5:54–70
  15. Roberts FJ. Definition of polymicrobial bacteremia. Rev Infect Dis. 1989;11:1029–1030
  16. Geerdes HF, Ziegler D, Lode H, Hund M, Loehr A, Fangmann W, et al. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis. 1992;15:991–1002
  17. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian university hospital, 1974–1979 and 1988–1989: changing etiology, clinical features, and outcome. Clin Infect Dis. 1994;19:246–256
  18. Pedersen G, Schønheyder HC, Sørensen HT. Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. Scand J Infect Dis. 1997;29:601–606
  19. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis. 1991;13:34–46
  20. Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald PP, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82:333–339
  21. Pedersen CB, Gøtzsche H, Møller JØ, Mortensen PB. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull. 2006;53:441–449
  22. Gradel KO, Søgaard M, Dethlefsen C, Nielsen H, Schønheyder HC. Magnitude of bacteraemia is a predictor of mortality during 1year of follow-up. Epidemiol Infect. 2009;137:94–101
  23. Schønheyder HC, Højbjerg T. The impact of the first notification of positive blood cultures on antibiotic-therapy: a 1-year survey. APMIS. 1995;103:37–44
  24. Pedersen G, Schønheyder HC, Sørensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia – a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect. 2003;9:793–802
  25. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control. 1988;1988(16):128–140
  26. Friedman ND, Kaye KS, Stout JE, McGerry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–797
  27. Lesens O, Hansmann Y, Brannigan E, Hopkins S, Meyer P, O'Connel B, et al. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?. Infect Control Hosp Epidemiol. 2005;26:204–209
  28. DANMAP . 2001 – Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Food and Humans in Denmark. Danish Zoonosis Centre. 2002;1600–2032ISSN
  29. Justesen T, Korsager B, Scheibel J. Vej-ledning i brug af antibiotika. In:  Aldershvile J,  Hansen MS,  Kampmann JP,  Vej-Hansen B editor. Lægeforeningens Medicinfortegnelse. 22nd ed. Copenhagen: Lægeforeningens forlag; 1999;p. 827–851
  30. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies: III. Design options. Am J Epidemiol. 1992;135:1042–1050
  31. Holmes B, Costas M, Thaker T, Stevens M. Evaluation of two BBL Crystal systems for identification of some clinically important gram-negative bacteria. J Clin Microbiol. 1994;32:2221–2224
  32. In:  Murray PR,  Baron EJ,  Pfaller MA,  Tenover FC,  Yolken RH editor. Manual of clinical microbiology. 7th ed. Washington DC: ASM Press; 1999;
  33. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis. 1983;5:35–53
  34. Pedersen G, Schønheyder HC. Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis. 1997;29:169–173
  35. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  36. Capdevila JA, Almirante B, Pahissa A, Planes AM, Ribera E, Martinez-Vazquez JM. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med. 1994;154:411–415
  37. Miller PJ, Farr BM. Morbidity and mortality associated with multiple episodes of nosocomial bloodstream infection: a cohort study. Infect Control Hosp Epidemiol. 1989;10:216–219
  38. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002;162:25–32
  39. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596

PII: S0163-4453(09)00391-0

doi: 10.1016/j.jinf.2009.12.007

Journal of Infection
Volume 60, Issue 3 , Pages 191-199 , March 2010

Article Tools

* Image Usage & Resolution